Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 5 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,520.8464 F1 · balance_after: Includes 169.6229 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 12, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 4 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By JM 2020 GRAT Disclosed balance after: 0 Read SEC document |
| May 12, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 3 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 4,862 Read SEC document |
| May 12, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 2 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By LM 2020 GRAT Disclosed balance after: 0 Read SEC document |
| May 11, 2021 Filed May 13, 2021 19:42 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
SaleCommon Stock | 3,432 | $208.33 | $714,988.56 |
DisclosureSEC source: 0001209191-21-032498 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,576 Read SEC document |
| May 06, 2021 Filed May 6, 2021 19:55 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 7,672 | $207.55 | $1,592,323.60 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.51 to $207.88, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2021 Filed May 5, 2021 20:05 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 40,626 | $207.19 | $8,417,126.25 |
DisclosureSEC source: 0001209191-21-030493 · doc4.xml · nonDerivative · entry 3 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,062 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.00 to $207.65, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2021 Filed May 4, 2021 19:42 UTC |
Wyatt Christopher F.SVP & Controller
|
SaleCommon Stock | 4,604 | $204.00 | $939,216.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 5 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,747 Read SEC document |
| May 04, 2021 Filed May 5, 2021 20:05 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 19,043 | $205.30 | $3,909,590.74 |
DisclosureSEC source: 0001209191-21-030493 · doc4.xml · nonDerivative · entry 2 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,688 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.00 to $205.54, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:55 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 19,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:55 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 11,328 | $206.34 | $2,337,419.52 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,550 Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:55 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 19,000 | $68.96 | $1,310,240.00 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 1 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,657.8464 F1 · balance_after: Includes 169.6229 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:05 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 21,584 | $205.21 | $4,429,151.20 |
DisclosureSEC source: 0001209191-21-030493 · doc4.xml · nonDerivative · entry 1 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,731 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.00 to $205.49, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:02 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 2,417 | $204.32 | $493,842.89 |
DisclosureSEC source: 0001209191-21-030489 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,899 Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:01 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 12,000 | $205.32 | $2,463,842.40 |
DisclosureSEC source: 0001209191-21-030488 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,381 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.32 to $205.34, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 1,843 | $203.06 | $374,235.34 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 8 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,315 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.00 to $203.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 4,990 | $0.00 Strike: $79.80 | $0.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · derivative · entry 7 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,260 Underlying: Common Stock · 4,990 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on May 4, 2017. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 7,010 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · derivative · entry 6 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,010 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC |
Wyatt Christopher F.SVP & Controller
|
Tax withholdingCommon Stock | 7,396 | $201.06 | $1,487,039.76 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 4 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,351 Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionCommon Stock | 4,990 | $79.80 | $398,202.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionCommon Stock | 7,010 | $69.58 | $487,755.80 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 23,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By DJP 2020 Trust Disclosed balance after: 56,247 Read SEC document |
| April 30, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 23,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 3 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| April 30, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 23,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 23,445 Read SEC document |
| April 30, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 23,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,085.1606 F1 · balance_after: Includes 2,085.1606 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 7,230 | $202.90 | $1,466,969.17 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 7 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,158 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.58 to $203.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 19,623 | $201.96 | $3,962,986.51 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 6 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,388 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.57 to $202.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 41,352 | $201.10 | $8,315,680.44 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 5 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,011 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.56 to $201.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 4,641 | $200.30 | $929,583.95 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 4 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,363 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.55, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2021 Filed May 3, 2021 19:38 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionStock Appreciation Right · Derivative | 5,930 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-21-029641 · doc4.xml · derivative · entry 4 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,930 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| April 29, 2021 Filed May 3, 2021 19:38 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 18,664 | $201.53 | $3,761,383.92 |
DisclosureSEC source: 0001209191-21-029641 · doc4.xml · nonDerivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,369.3238 F1 · balance_after: Includes 2,109.3238 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| April 29, 2021 Filed May 3, 2021 19:38 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 3,794 | $201.94 | $766,160.36 |
DisclosureSEC source: 0001209191-21-029641 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,033.3238 F1 · balance_after: Includes 2,109.3238 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| April 29, 2021 Filed May 3, 2021 19:38 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 5,930 | $81.96 | $486,022.80 |
DisclosureSEC source: 0001209191-21-029641 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,827.3238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,109.3238 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 42,578 | $200.24 | $8,525,848.52 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 3 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,004 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.92 to $200.91, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 21,508 | $199.53 | $4,291,385.85 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 2 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,582 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.995 to $199.91, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:37 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
SaleCommon Stock | 8,759 | $198.75 | $1,740,861.76 |
DisclosureSEC source: 0001209191-21-029404 · doc4.xml · nonDerivative · entry 1 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,090 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.50 to $198.9875, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:36 UTC |
MICHELSON MICHAEL WDirector
|
GrantCommon Stock | 1,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029402 · doc4.xml · nonDerivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,776 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award and 554 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2022 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:37 UTC |
Riley Wayne JosephDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029403 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:35 UTC |
HOLLIDAY CHARLES O JRDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029401 · doc4.xml · nonDerivative · entry 1 HOLLIDAY CHARLES O JR · CIK 0001127289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,053 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:33 UTC |
Frist William RDirector · 10% owner
|
GrantCommon Stock, par value $0.01 per share | 1,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029400 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,471 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award and 554 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2022 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:31 UTC |
FRIST THOMAS F IIIDirector · 10% owner
|
GrantCommon Stock, par value $0.01 per share | 1,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029398 · doc4.xml · nonDerivative · entry 1 FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,918 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award and 1,057 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2022 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:01 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029382 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,581 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:01 UTC |
Dennis Robert JDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029381 · doc4.xml · nonDerivative · entry 1 Dennis Robert J · CIK 0001295441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,663 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 19:59 UTC |
CROFTON MEGDirector
|
GrantCommon Stock | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029380 · doc4.xml · nonDerivative · entry 1 CROFTON MEG · CIK 0001665104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,156 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2022 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| April 27, 2021 Filed Apr 27, 2021 20:19 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 38,390 | $199.91 | $7,674,594.81 |
DisclosureSEC source: 0001209191-21-028737 · doc4.xml · nonDerivative · entry 16 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,513.9415 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.50 to $200.00, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes 2,068.9415 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| April 27, 2021 Filed Apr 27, 2021 20:19 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 25,000 | $200.08 | $5,002,122.50 |
DisclosureSEC source: 0001209191-21-028737 · doc4.xml · nonDerivative · entry 15 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2021 Trust Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.395, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2021 Filed Apr 27, 2021 20:19 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028737 · doc4.xml · nonDerivative · entry 14 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2021 Trust Disclosed balance after: 25,000 Read SEC document |
| April 27, 2021 Filed Apr 27, 2021 20:19 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028737 · doc4.xml · nonDerivative · entry 13 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,903.9415 F1 · balance_after: Includes 2,068.9415 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| April 27, 2021 Filed Apr 27, 2021 20:19 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028737 · doc4.xml · nonDerivative · entry 12 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,903.9415 F1 · balance_after: Includes 2,068.9415 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.